Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Nov 2015

Graziano Paolo, de Marinis Filippo, Gori Bruno, Gasbarra Rita, Migliorino Rita, De Santis Stefano, Pelosi Giuseppe, Leone Alvaro

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to ErbB Receptors

Share to Gene Deletion

Share to Liver Neoplasms

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 24752053
DOI: 10.1200/JCO.2013.49.5697

Genes

EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology.PMID 24752053Read ↗

[Advances of heterogeneity of EGFR in non-small cell lung cancer].Semantic proximity Read ↗

Spatiotemporal T790M heterogeneity in a patient with EGFR-mutant non-small-cell lung cancer.Semantic proximity Read ↗

Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationSemantic proximity Read ↗

Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells.Semantic proximity Read ↗

Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients: Potential Clinical Impact on Subsequent third-generation TKI Treatment.Semantic proximity Read ↗

Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.Semantic proximity Read ↗

Does EGFR targeted therapy change the natural history of EGFR mutant status?Semantic proximity Read ↗

Targeting the EGFR T790M mutation in non-small-cell lung cancer.Semantic proximity Read ↗

Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Patient With Lung Adenocarcinoma and Sarcomatoid Transformation.Semantic proximity Read ↗

Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First-line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure.Semantic proximity Read ↗

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancerSemantic proximity Read ↗

Heterogeneity of EGFR-mutant clones and PD-L1 highly expressing clones affects treatment efficacy of EGFR-TKI and PD-1 inhibitor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.